Anjay Rastogi

Title(s)Professor of Clinical , Medicine
SchoolMedicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study. Clin Kidney J. 2024 May; 17(5):sfae083. Rastogi A, Pollack CV, Sánchez Lázaro IJ, Lesén E, Arnold M, Franzén S, Allum A, Hernández I, Murohara T, Kanda E. PMID: 38699484; PMCID: PMC11062025.
      View in: PubMed   Mentions: 1  
    2. Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2. Am J Nephrol. 2024; 55(3):329-333. Fishbane S, Clegg DJ, Lerma EV, Rastogi A, Budden J, Morin I, Wen W, Menzaghi F, Topf J. PMID: 38253036; PMCID: PMC11152003.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    3. Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Mar; 41(3):1151-1167. Tangri N, Rastogi A, Nekeman-Nan C, Hong LS, Ozaki A, Franzén S, Sofue T. PMID: 38240949; PMCID: PMC10879247.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    4. Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. J Prim Care Community Health. 2024 Jan-Dec; 15:21501319241259905. Rastogi A, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P, Chertow GM. PMID: 39143759; PMCID: PMC11327967.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-Trial Follow-Up of SPRINT. Clin J Am Soc Nephrol. 2024 Feb 01; 19(2):213-223. Drawz PE, Lenoir KM, Rai NK, Rastogi A, Chu CD, Rahbari-Oskoui FF, Whelton PK, Thomas G, McWilliams A, Agarwal AK, Suarez MM, Dobre M, Powell J, Rocco MV, Lash JP, Oparil S, Raj DS, Dwyer JP, Rahman M, Soman S, Townsend RR, Pemu P, Horwitz E, Ix JH, Tuot DS, Ishani A, Pajewski NM. PMID: 37883184; PMCID: PMC10861101.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Multimodal efforts to slow the progression of chronic kidney disease in patients with type 2 diabetes mellitus. J Diabetes Complications. 2023 08; 37(8):108515. Rastogi A, Weir MR. PMID: 37356235.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis. Expert Rev Clin Pharmacol. 2023 May; 16(5):387-400. Rastogi A, Fishbane S, Lerma E. PMID: 37010031.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease. J Clin Med. 2023 Apr 12; 12(8). Rastogi A, Januzzi JL. PMID: 37109162; PMCID: PMC10143176.
      View in: PubMed   Mentions: 4  
    9. Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia. BMC Nephrol. 2023 01 19; 24(1):18. Kanda E, Rastogi A, Murohara T, Lesén E, Agiro A, Arnold M, Chen G, Yajima T, Järbrink K, Pollack CV. PMID: 36658531; PMCID: PMC9854063.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    10. Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial. Clin J Am Soc Nephrol. 2022 09; 17(9):1325-1336. Coyne DW, Singh AK, Lopes RD, Bailey CK, DiMino TL, Huang C, Connaire J, Rastogi A, Kim SG, Orias M, Shah S, Patel V, Cobitz AR, Wanner C. PMID: 35918106; PMCID: PMC9625096.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    11. Course of Hyperkalemia in Patients on Hemodialysis. Int J Nephrol. 2022; 2022:6304571. Spinowitz B, Fishbane S, Fukagawa M, Ford M, Guzman N, Rastogi A. PMID: 35531468; PMCID: PMC9071981.
      View in: PubMed   Mentions: 1  
    12. Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study. J Am Soc Nephrol. 2022 04; 33(4):850-866. Fishbane S, Pollock CA, El-Shahawy M, Escudero ET, Rastogi A, Van BP, Frison L, Houser M, Pola M, Little DJ, Guzman N, Pergola PE. PMID: 35361724; PMCID: PMC8970450.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    13. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial. JAMA Neurol. 2022 04 01; 79(4):380-389. Dolui S, Detre JA, Gaussoin SA, Herrick JS, Wang DJJ, Tamura MK, Cho ME, Haley WE, Launer LJ, Punzi HA, Rastogi A, Still CH, Weiner DE, Wright JT, Williamson JD, Wright CB, Bryan RN, Bress AP, Pajewski NM, Nasrallah IM. PMID: 35254390; PMCID: PMC8902686.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    14. Acute interstitial nephritis observed with three different triggering agents. Clin Case Rep. 2022 Mar; 10(3):e05432. Nobakht N, Hanna RM, Kamgar M, Sinclair J, Simon L, Emami S, Sisk A, Rastogi A. PMID: 35340649; PMCID: PMC8933633.
      View in: PubMed   Mentions: 1  
    15. Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE. BMC Nephrol. 2022 02 08; 23(1):59. Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S. PMID: 35135481; PMCID: PMC8826669.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    16. Hypokalemia Events With Sodium Zirconium Cyclosilicate and Placebo in Hemodialysis Patients. Kidney Int Rep. 2022 Apr; 7(4):908-912. Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S. PMID: 35497779; PMCID: PMC9039482.
      View in: PubMed   Mentions:
    17. Dose effect analysis of sodium zirconium cyclosilicate in hemodialysis patients. Hemodial Int. 2022 04; 26(2):274-277. Spinowitz B, McCafferty K, Fishbane S, Fukagawa M, Guzman N, Ford M, Rastogi A, Bhandari S. PMID: 34927340; PMCID: PMC9299877.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT. Circ Heart Fail. 2021 12; 14(12):e008322. Upadhya B, Willard JJ, Lovato LC, Rocco MV, Lewis CE, Oparil S, Cushman WC, Bates JT, Bello NA, Aurigemma G, Johnson KC, Rodriguez CJ, Raj DS, Rastogi A, Tamariz L, Wiggers A, Kitzman DW, SPRINT Research Group. PMID: 34823375; PMCID: PMC8692397.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    19. Effectiveness of Sodium Zirconium Cyclosilicate in Hemodialysis Patients With Severe Hyperkalemia. Kidney Int Rep. 2021 Dec; 6(12):3074-3078. Ford M, Fishbane S, Spinowitz B, Rastogi A, Guzman N, McCafferty K. PMID: 34901576; PMCID: PMC8640539.
      View in: PubMed   Mentions: 3  
    20. Sodium zirconium cyclosilicate for the management of chronic hyperkalemia in kidney disease, a novel agent. Expert Rev Clin Pharmacol. 2021 Sep; 14(9):1055-1064. Rastogi A, Hanna RM, Mkrttchyan A, Khalid M, Yaqoob S, Shaffer K, Dhawan P, Nobakht N, Kamgar M, Goshtaseb R, Sarmosyan K, Gnarini M, Wassef O, Lerma E. PMID: 34227913.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Anemia management for home dialysis including the new US public policy initiative. Kidney Int Suppl (2011). 2021 Apr; 11(1):59-69. Rastogi A, Lerma EV. PMID: 33777496; PMCID: PMC7983021.
      View in: PubMed   Mentions: 2  
    22. Effect of Intensive Versus Standard Blood Pressure Control on Stroke Subtypes. Hypertension. 2021 04; 77(4):1391-1398. Wright CB, Auchus AP, Lerner A, Ambrosius WT, Ay H, Bates JT, Chen J, Meschia JF, Pancholi S, Papademetriou V, Rastogi A, Sweeney M, Willard JJ, Yee J, Oparil S. PMID: 33583199; PMCID: PMC8224947.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Clinical Management of Hyperkalemia. Mayo Clin Proc. 2021 03; 96(3):744-762. Palmer BF, Carrero JJ, Clegg DJ, Colbert GB, Emmett M, Fishbane S, Hain DJ, Lerma E, Onuigbo M, Rastogi A, Roger SD, Spinowitz BS, Weir MR. PMID: 33160639.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    24. One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism. Nephrol Dial Transplant. 2020 10 01; 35(10):1769-1778. Bushinsky DA, Chertow GM, Cheng S, Deng H, Kopyt N, Martin KJ, Rastogi A, Ureña-Torres P, Vervloet M, Block GA. PMID: 30859218; PMCID: PMC7538239.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    25. Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop. Am J Kidney Dis. 2021 02; 77(2):255-263. Cho Y, Tong A, Craig JC, Mustafa RA, Chapman A, Perrone RD, Ahn C, Fowler K, Torres V, Gansevoort RT, Ong ACM, Coolican H, Tze-Wah Kao J, Harris T, Gutman T, Shen JI, Viecelli AK, Johnson DW, Au E, El-Damanawi R, Logeman C, Ju A, Manera KE, Chonchol M, Odland D, Baron D, Pei Y, Sautenet B, Rastogi A, Sharma A, Rangan G, SONG-PKD Workshop Investigators. PMID: 32771648.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    26. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis. 2020 12; 76(6):765-774. Potok OA, Ix JH, Shlipak MG, Katz R, Hawfield AT, Rocco MV, Ambrosius WT, Cho ME, Pajewski NM, Rastogi A, Rifkin DE. PMID: 32682697; PMCID: PMC8896529.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    27. Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial
. Clin Nephrol. 2020 Jul; 94(1):26-35. Nowak KL, Chonchol M, Jovanovich A, You Z, Ambrosius WT, Cho ME, Glasser S, Lash J, Simmons DL, Taylor A, Weiner D, Rastogi A, Oparil S, Supiano MA. PMID: 32449678; PMCID: PMC7814777.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study. Nephron. 2020; 144(9):428-439. Covic AC, Sprague SM, Rastogi A, Ketteler M, Walpen S, Perrin A, Floege J. PMID: 32585670; PMCID: PMC7592954.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    29. Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm. J Ren Nutr. 2021 01; 31(1):21-34. Rastogi A, Bhatt N, Rossetti S, Beto J. PMID: 32386937.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    30. Multiple reasons for living donor denial: A single-center experience. Clin Transplant. 2020 05; 34(5):e13812. Lum EL, Shen JI, Beaumont JL, Treat E, Rastogi A, Waterman A, Gritsch HA. PMID: 32017232; PMCID: PMC7242155.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. A case of renal and splenic LECT 2 amyloidosis: A recently recognized cause of renal and systemic amyloidosis. Saudi J Kidney Dis Transpl. 2020 Mar-Apr; 31(2):508-514. Shye M, Sisk A, Schulze C, Barsoum M, Mikhail M, Arman F, Rastogi A, Hanna RM. PMID: 32394925.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD. Clin J Am Soc Nephrol. 2020 03 06; 15(3):349-358. Malhotra R, Katz R, Jotwani V, Ambrosius WT, Raphael KL, Haley W, Rastogi A, Cheung AK, Freedman BI, Punzi H, Rocco MV, Ix JH, Shlipak MG. PMID: 32111704; PMCID: PMC7057300.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    33. Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical Review. Kidney Med. 2020 Mar-Apr; 2(2):196-208. Nobakht N, Hanna RM, Al-Baghdadi M, Ameen KM, Arman F, Nobahkt E, Kamgar M, Rastogi A. PMID: 32734239; PMCID: PMC7380379.
      View in: PubMed   Mentions: 15  
    34. Blood Pressure Control and the Association With Diabetes Mellitus Incidence: Results From SPRINT Randomized Trial. Hypertension. 2020 02; 75(2):331-338. Roumie CL, Hung AM, Russell GB, Basile J, Kreider KE, Nord J, Ramsey TM, Rastogi A, Sweeney ME, Tamariz L, Kostis WJ, Williams JS, Zias A, Cushman WC, SPRINT Research Group. PMID: 31865790; PMCID: PMC7015147.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    35. Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction: Potential Role of Diuretics. JACC Heart Fail. 2019 12; 7(12):1032-1041. Upadhya B, Lovato LC, Rocco M, Lewis CE, Oparil S, Cushman WC, Kostis JB, Rodriguez CJ, Cho ME, Cloud LW, Rastogi A, Rosendorff C, Kitzman DW, SPRINT Research Group. PMID: 31779925; PMCID: PMC7927202.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. Equivalent Efficacy and Decreased Rate of Overcorrection in Patients With Syndrome of Inappropriate Secretion of Antidiuretic Hormone Given Very Low-Dose Tolvaptan. Kidney Med. 2020 Jan-Feb; 2(1):20-28. Hanna RM, Velez JC, Rastogi A, Nguyen MK, Kamgar MK, Moe K, Arman F, Hasnain H, Nobakht N, Selamet U, Kurtz I. PMID: 32734225; PMCID: PMC7380356.
      View in: PubMed   Mentions: 8  
    37. Blood Pressure and Living Kidney Donors: A Clinical Perspective. Transplant Direct. 2019 Oct; 5(10):e488. Rastogi A, Yuan S, Arman F, Simon L, Shaffer K, Kamgar M, Nobakht N, Bromberg JS, Weir MR. PMID: 31723583; PMCID: PMC6791603.
      View in: PubMed   Mentions: 3  
    38. Autosomal dominant polycystic kidney disease: updated perspectives. Ther Clin Risk Manag. 2019; 15:1041-1052. Rastogi A, Ameen KM, Al-Baghdadi M, Shaffer K, Nobakht N, Kamgar M, Lerma EV. PMID: 31692482; PMCID: PMC6716585.
      View in: PubMed   Mentions: 12  
    39. Three Patients with Lithium-Associated Hyperparathyroidism: Literature Review Regarding Medical and Surgical Management. Case Rep Nephrol Dial. 2019 May-Aug; 9(2):108-118. Hanna RM, Hasnain H, Sangalang MD, Han J, Arasu A, Arman F, Barsoum M, Poa H, Rastogi A, Harari A. PMID: 31559266; PMCID: PMC6751439.
      View in: PubMed   Mentions:
    40. Secondary membranous nephropathy in a patient with myasthenia gravis without thymic disease, and partial remission induced by adrenocorticotropic hormone therapy. SAGE Open Med Case Rep. 2019; 7:2050313X19869764. Hanna RM, Arman F, Selamet U, Wallace WD, Barsoum M, Rastogi A, Nobakht N, Shieh P. PMID: 31448123; PMCID: PMC6689923.
      View in: PubMed   Mentions: 1  
    41. Development of Collapsing Focal and Segmental Glomerulosclerosis After Receiving Intravitreal Vascular Endothelial Growth Factor Blockade. Kidney Int Rep. 2019 Oct; 4(10):1508-1512. Nobakht N, Nguyen HA, Kamgar MK, Abdelnour L, Rastogi A, Hanna RM. PMID: 31701065; PMCID: PMC6829182.
      View in: PubMed   Mentions: 7  
    42. Everolimus worsening chronic proteinuria in patient with diabetic nephropathy post liver transplantation. Saudi J Kidney Dis Transpl. 2019 Jul-Aug; 30(4):989-994. Hanna RM, Yanny B, Arman F, Barsoum M, Mikhail M, Al Baghdadi M, Rastogi A, Wallace W, Saab S. PMID: 31464262.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients. Nephrol Dial Transplant. 2019 07 01; 34(7):1163-1170. Ketteler M, Sprague SM, Covic AC, Rastogi A, Spinowitz B, Rakov V, Walpen S, Floege J. PMID: 29846719; PMCID: PMC6603395.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    44. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia. J Am Soc Nephrol. 2019 09; 30(9):1723-1733. Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S. PMID: 31201218; PMCID: PMC6727265.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    45. Erratum. Nephrol Dial Transplant. 2019 05 15; 1642. Bushinsky DA, Chertow GM, Cheng S, Deng H, Kopyt N, Martin KJ, Rastogi A, Ureña-Torres P, Vervloet M, Block GA. PMID: 31093680; PMCID: PMC7473800.
      View in: PubMed   Mentions: 1     Fields:    
    46. The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury. Kidney Int. 2019 08; 96(2):470-479. Bullen AL, Katz R, Lee AK, Anderson CAM, Cheung AK, Garimella PS, Jotwani V, Haley WE, Ishani A, Lash JP, Neyra JA, Punzi H, Rastogi A, Riessen E, Malhotra R, Parikh CR, Rocco MV, Wall BM, Bhatt UY, Shlipak MG, Ix JH, Estrella MM. PMID: 31262489; PMCID: PMC6650383.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    47. Primary membranous nephropathy with concomitant IgA nephropathy. Saudi J Kidney Dis Transpl. 2019 Mar-Apr; 30(2):531-536. Khorsan R, Hanna RM, Ameen K, Arman F, Nobakht N, Hasnain H, Hyunh A, Rastogi A. PMID: 31031392.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    48. Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment. Int J Nephrol Renovasc Dis. 2018; 11:313-319. Arman F, Barsoum M, Selamet U, Shakeri H, Wassef O, Mikhail M, Rastogi A, Hanna RM. PMID: 30538527; PMCID: PMC6255047.
      View in: PubMed   Mentions: 4  
    49. A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan. J Am Soc Nephrol. 2018 10; 29(10):2458-2470. Chebib FT, Perrone RD, Chapman AB, Dahl NK, Harris PC, Mrug M, Mustafa RA, Rastogi A, Watnick T, Yu ASL, Torres VE. PMID: 30228150; PMCID: PMC6171265.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    50. Hypercalcemia-induced acute kidney injury in a Caucasian female due to radiographically silent systemic sarcoidosis. Clin Nephrol Case Stud. 2018; 6:21-26. Hanna RM, Kaldas M, Arman F, Wang M, Hammer T, Sinkowitz D, Rastogi A. PMID: 30206511; PMCID: PMC6125993.
      View in: PubMed   Mentions: 3  
    51. Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency. Case Rep Nephrol Dial. 2018 May-Aug; 8(2):171-177. Hanna RM, Selamet U, Bui P, Sun SF, Shenouda O, Nobakht N, Barsoum M, Arman F, Rastogi A. PMID: 30197906; PMCID: PMC6120420.
      View in: PubMed   Mentions: 14  
    52. Case Report: Patient with Hepatitis C, p-ANCA, and Cryoglobulin Antibodies Presenting with Necrotizing Crescentic p-ANCA Glomerulonephritis. Case Rep Nephrol Dial. 2018 May-Aug; 8(2):161-170. Hanna RM, So N, Kaldas M, Hou J, Arman F, Sangalang M, Yanny B, Selamet U, Saab S, Nobakht N, Rastogi A. PMID: 30197905; PMCID: PMC6120379.
      View in: PubMed   Mentions: 3  
    53. Mandating Staffing Ratios in Hemodialysis Facilities: California SB 349 and Unintended Consequences. Clin J Am Soc Nephrol. 2018 07 06; 13(7):1110-1112. Rastogi A, Chertow GM. PMID: 29875201; PMCID: PMC6032581.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    54. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial. Ann Intern Med. 2017 Sep 19; 167(6):375-383. Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, Cheung AK, Cohen D, Freedman BI, Hawfield AT, Killeen AA, Kimmel PL, Lash J, Papademetriou V, Rahman M, Rastogi A, Servilla K, Townsend RR, Wall B, Whelton PK, SPRINT Research Group. PMID: 28869987; PMCID: PMC8545525.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    55. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care. 2017 Aug 09. Bress AP, King JB, Kreider KE, Beddhu S, Simmons DL, Cheung AK, Zhang Y, Doumas M, Nord J, Sweeney ME, Taylor AA, Herring C, Kostis WJ, Powell J, Rastogi A, Roumie CL, Wiggers A, Williams JS, Yunis R, Zias A, Evans GW, Greene T, Rocco MV, Cushman WC, Reboussin DM, Feinglos MN, Papademetriou V, SPRINT Research Group. PMID: 28793997; PMCID: PMC5606306.
      View in: PubMed   Mentions: 26     Fields:    
    56. Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide. Nephrol Dial Transplant. 2017 Aug 01; 32(8):1330-1338. Covic AC, Floege J, Ketteler M, Sprague SM, Lisk L, Rakov V, Rastogi A. PMID: 27342579; PMCID: PMC5837623.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    57. A Case of Kidney Involvement in Primary Sjögren's Syndrome. Am J Case Rep. 2017 Jun 03; 18:622-626. Arman F, Shakeri H, Nobakht N, Rastogi A, Kamgar M. PMID: 28577018; PMCID: PMC5467668.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    58. Erdheim-Chester Disease Presenting with Secondary Hypertension as a Result of Bilateral, Proximal Renal Artery Stenosis: A Case Report. Case Rep Nephrol Dial. 2017 May-Aug; 7(2):55-62. Arman F, Shakeri H, Nobakht N, Rastogi A, Kamgar M. PMID: 28612007; PMCID: PMC5465515.
      View in: PubMed   Mentions: 1  
    59. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial. Circ Heart Fail. 2017 Apr; 10(4). Upadhya B, Rocco M, Lewis CE, Oparil S, Lovato LC, Cushman WC, Bates JT, Bello NA, Aurigemma G, Fine LJ, Johnson KC, Rodriguez CJ, Raj DS, Rastogi A, Tamariz L, Wiggers A, Kitzman DW, SPRINT Research Group. PMID: 28364091; PMCID: PMC5384646.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    60. Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide. Front Med (Lausanne). 2017; 4:17. Patel S, Nguyen DS, Rastogi A, Nguyen MK, Nguyen MK. PMID: 28352627; PMCID: PMC5348528.
      View in: PubMed   Mentions: 6  
    61. Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients. Am J Nephrol. 2016; 44(2):104-12. Sprague SM, Covic AC, Floege J, Ketteler M, Botha J, Chong EM, Rastogi A. PMID: 27434393.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    62. New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease. Curr Hypertens Rep. 2016 Jul; 18(7):55. Rastogi A, Arman F, Alipourfetrati S. PMID: 27230070.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    63. Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial. Hypertension. 2016 Mar; 67(3):550-5. Chang TI, Evans G, Cheung AK, Cushman WC, Diamond MJ, Dwyer JP, Huan Y, Kitzman D, Kostis JB, Oparil S, Rastogi A, Roumie CL, Sahay R, Stafford RS, Taylor AA, Wright JT, Chertow GM, SPRINT Study Research Group. PMID: 26865200; PMCID: PMC4755350.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    64. Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia. J Am Soc Nephrol. 2016 Apr; 27(4):1234-44. Holdstock L, Meadowcroft AM, Maier R, Johnson BM, Jones D, Rastogi A, Zeig S, Lepore JJ, Cobitz AR. PMID: 26494831; PMCID: PMC4814173.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCTClinical Trials
    65. Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients. Nephrol Dial Transplant. 2015 Jun; 30(6):1037-46. Floege J, Covic AC, Ketteler M, Mann JF, Rastogi A, Spinowitz B, Chong EM, Gaillard S, Lisk LJ, Sprague SM, Sucroferric Oxyhydroxide Study Group. PMID: 25691681; PMCID: PMC4438742.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    66. Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation. PLoS One. 2014; 9(12):e116530. Bacchetta J, Chun RF, Gales B, Zaritsky JJ, Leroy S, Wesseling-Perry K, Boregaard N, Rastogi A, Salusky IB, Hewison M. PMID: 25549329; PMCID: PMC4280222.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    67. A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients. Kidney Int. 2014 Sep; 86(3):638-47. Floege J, Covic AC, Ketteler M, Rastogi A, Chong EM, Gaillard S, Lisk LJ, Sprague SM, PA21 Study Group. PMID: 24646861; PMCID: PMC4150998.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCTClinical Trials
    68. Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease. Ther Adv Cardiovasc Dis. 2013 Dec; 7(6):322-42. Rastogi A. PMID: 24327730; PMCID: PMC3917706.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    69. A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure. Cytometry B Clin Cytom. 2014 May; 86(3):175-82. Raza A, Ravandi F, Rastogi A, Bubis J, Lim SH, Weitz I, Castro-Malaspina H, Galili N, Jawde RA, Illingworth A. PMID: 24227693; PMCID: PMC5594745.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    70. Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis. Nephrol Dial Transplant. 2014 Feb; 29(2):437-41. Zaritsky J, Rastogi A, Fischmann G, Yan J, Kleinman K, Chow G, Gales B, Salusky IB, Wesseling-Perry K. PMID: 24009282; PMCID: PMC3910340.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    71. Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence. BMC Nephrol. 2013 Jul 18; 14:153. Covic A, Rastogi A. PMID: 23865421; PMCID: PMC3728082.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    72. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials. Nephrol Dial Transplant. 2013 Jul; 28(7):1888-98. Ornt DB, Larive B, Rastogi A, Rashid M, Daugirdas JT, Hernandez A, Kurella Tamura M, Suri RS, Levin NW, Kliger AS, Frequent Hemodialysis Network Trial Group. PMID: 23358899; PMCID: PMC3707527.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    73. Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment. Antimicrob Agents Chemother. 2013 Mar; 57(3):1192-200. Moise PA, Amodio-Groton M, Rashid M, Lamp KC, Hoffman-Roberts HL, Sakoulas G, Yoon MJ, Schweitzer S, Rastogi A. PMID: 23254428; PMCID: PMC3591880.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    74. Internet-based tools to assess diet and provide feedback in chronic kidney disease stage IV: a pilot study. J Ren Nutr. 2013 Mar; 23(2):e33-42. Murali S, Arab L, Vargas R, Rastogi A, Ang A, Shetty N. PMID: 22819321.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    75. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012 Jun; 64(6):797-808. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM, American College of Rheumatology. PMID: 22556106; PMCID: PMC3437757.
      View in: PubMed   Mentions: 448     Fields:    Translation:HumansPHPublic Health
    76. Reducing cardiorenal risk through combination therapy with a direct renin inhibitor. J Clin Hypertens (Greenwich). 2011 Nov; 13(11):848-55. Rastogi A, Rashid M, Wright RF. PMID: 22051431; PMCID: PMC8108923.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    77. The cardiorenal syndrome. Int J Nephrol. 2011; 2011:982092. Rosner MH, Rastogi A, Ronco C. PMID: 21761003; PMCID: PMC3133432.
      View in: PubMed   Mentions: 6  
    78. Limitations of angiotensin inhibition. Nat Rev Nephrol. 2011 06; 7(6):356-9. Nobakht N, Kamgar M, Rastogi A, Schrier RW. PMID: 21502972.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    79. Impact of sleep quality on cardiovascular outcomes in hemodialysis patients: results from the frequent hemodialysis network study. Am J Nephrol. 2011; 33(5):398-406. Unruh M, Kurella Tamura M, Larive B, Rastogi A, James S, Schiller B, Gassman J, Chan C, Lockridge R, Kliger A. PMID: 21474924; PMCID: PMC3080580.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    80. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010 Dec 09; 363(24):2287-300. FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS. PMID: 21091062; PMCID: PMC3042140.
      View in: PubMed   Mentions: 305     Fields:    Translation:Humans
    81. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol. 2010 Jun; 5(6):1010-4. Zaritsky J, Young B, Gales B, Wang HJ, Rastogi A, Westerman M, Nemeth E, Ganz T, Salusky IB. PMID: 20299375; PMCID: PMC2879302.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    82. Technological advances in renal replacement therapy: five years and beyond. Clin J Am Soc Nephrol. 2009 Dec; 4 Suppl 1:S132-6. Rastogi A, Nissenson AR. PMID: 19995997.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    83. Renal replacement therapy in the elderly. Clin Geriatr Med. 2009 Aug; 25(3):529-42. Ye X, Rastogi A, Nissenson AR. PMID: 19765494.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. Renal function impacts outcomes after intestinal transplantation. Transplantation. 2008 Jul 15; 86(1):117-22. Watson MJ, Venick RS, Kaldas F, Rastogi A, Gordon SA, Colangelo J, Esmailian Y, McDiarmid SV, Busuttil RW, Farmer DG. PMID: 18622288.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    85. The cardiorenal connection in heart failure. Curr Cardiol Rep. 2008 May; 10(3):190-7. Rastogi A, Fonarow GC. PMID: 18489862.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    86. Spurious elevation in serum creatinine caused by ingestion of nitromethane: implication for the diagnosis and treatment of methanol intoxication. Am J Kidney Dis. 2008 Jul; 52(1):181-7. Rastogi A, Itagaki B, Bajwa M, Kraut JA. PMID: 18589218.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    87. Disease management in chronic kidney disease. Adv Chronic Kidney Dis. 2008 Jan; 15(1):19-28. Rastogi A, Linden A, Nissenson AR. PMID: 18155106.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    88. The future of renal replacement therapy. Adv Chronic Kidney Dis. 2007 Jul; 14(3):249-55. Rastogi A, Nissenson AR. PMID: 17603978.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    89. True hyponatremia secondary to intravenous immunoglobulin. Clin Exp Nephrol. 2006 Jun; 10(2):124-6. Nguyen MK, Rastogi A, Kurtz I. PMID: 16791398.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    Anjay's Networks
    Concepts (290)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (67)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California